Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
33.21
+0.07 (0.21%)
Dec 20, 2024, 4:00 PM EST - Market closed
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of $4.13 billion as of December 20, 2024. Its market cap has decreased by -45.56% in one year.
Market Cap
4.13B
Enterprise Value
4.20B
1-Year Change
-45.56%
Ranking
Category
Stock Price
$33.21
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.07M to $4.13B, an increase of 497.78%. That is a compound annual growth rate of 28.56%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integer Holdings | 4.46B |
| TG Therapeutics | 4.44B |
| PROCEPT BioRobotics | 4.37B |
| Axsome Therapeutics | 4.35B |
| ADMA Biologics | 4.23B |
| Arcellx | 4.07B |
| Ultragenyx Pharmaceutical | 4.01B |
| Scholar Rock Holding | 3.94B |